M | O | C Cancer Care & Research Centre - Comprehensive Analysis Report

Summary

M | O | C Cancer Care & Research Centre (MOC) is a pioneering network established in 2018 by four oncologists to provide comprehensive oncology and hematology healthcare services in India. Its core mission is to bridge critical gaps in the country's cancer care infrastructure by enhancing proximity and affordability for patients. MOC has grown to become one of India's largest chains of community cancer centers. The company envisions expanding across all major locations in India, delivering high-quality, up-to-date medical interventions and seamless healthcare services through state-of-the-art facilities, thereby transforming cancer care accessibility and standards.

1. Strategic Focus & Objectives

Core Objectives

MOC's primary objectives are centered around delivering quality and affordable cancer care through a decentralized network of community day-care oncology centers.

Enhanced Accessibility: Making cancer treatment available near patients' homes to reduce logistical and financial burdens.

Personalized Care: Providing compassionate, tailored care to each patient.

Standardization: Unifying fragmented cancer care markets through strategic growth initiatives including mergers, acquisitions, brownfield, and greenfield projects.

Specialization Areas

MOC specializes in the medical management of cancer, offering a wide array of advanced treatments.

Medical Oncology: Expertise in conventional chemotherapy, targeted therapy, and immunotherapy for both solid and liquid cancers.

Comprehensive Supportive Services: Provision of genetic counseling, onco-nutrition, onco-physiotherapy, and palliative care to ensure holistic patient support.

Advanced Diagnostics: In-house pathology services for high-tech genetic testing and plans for a molecular oncology lab.

Target Markets

MOC primarily targets patients across various regions in India, focusing on areas with inadequate cancer care infrastructure or where existing services are significantly costly or distant.

Primary Market Segments: Patients in Western and Central India, including major cities like Mumbai, Pune, Ahmedabad, Indore, and Chhattisgarh, as well as broader regions of Maharashtra.

Expansion Markets: Future expansion into Delhi NCR and other parts of India.

International Presence: Currently has a presence in Tanzania, indicating potential for further international reach.

Market Positioning: Positions itself as a provider of accessible, affordable, and high-quality cancer care, directly addressing the critical needs of a large patient population in India.

2. Financial Overview

Funding History

MOC has successfully raised a total of $28 million in funding to date, supporting its growth and expansion initiatives.

First Round (2023): Secured $10 million from Tata Capital Healthcare Fund.

Fund Utilization: Employed for expanding operations and enhancing technological capabilities.

Impact on Growth: Enabled significant operational scaling and infrastructure improvements.

Second Round (February 2025): Raised an additional $18 million in growth capital in a funding round led by Elevation Capital.

Fund Utilization: Earmarked for further operational expansion, establishing new centers, and diversifying service offerings.

Impact on Growth: Poised to accelerate national growth and broaden the scope of advanced cancer treatments.

As of March 31, 2025, an associated legal entity, Cellcure Cancer Centre Private Limited, reported an annual revenue of $39.6 million.

3. Product Pipeline

Key Products/Services

MOC Cancer Care & Research Centre is actively developing and integrating advanced therapies to enhance patient care.

Advanced Medical Oncology Treatments:

Description: Includes conventional chemotherapy, targeted therapy, and immunotherapy.

Development Stage: Currently offered across its network.

Target Market/Condition: A broad spectrum of solid and liquid cancers.

Key Features and Benefits: Provides up-to-date medical interventions tailored to individual patient needs.

CAR-T Cell Therapy:

Description: A revolutionary advancement aimed at harnessing a patient's own immune system to combat specific blood cancers.

Development Stage: Imminent introduction, indicating late-stage planning and integration.

Target Market/Condition: Patients with certain blood cancers, including leukemias, myeloma, and lymphomas.

Expected Timeline: Set for introduction in the near future.

Key Features and Benefits: Aims to make highly advanced and potentially curative treatments more accessible and affordable in India.

Clinical Research Participation:

Description: Participation in major landmark clinical trials.

Development Stage: Ongoing research and collaboration.

Target Market/Condition: Patients eligible for cutting-edge, high-end research products.

Key Features and Benefits: Provides patients access to novel therapies not yet widely available.

Molecular Oncology Lab:

Description: Development of advanced diagnostic capabilities.

Development Stage: Planned initiative.

Target Market/Condition: All cancer patients requiring precise molecular profiling and genetic testing.

Key Features and Benefits: Will enable more personalized and targeted treatment approaches.

Preventive Oncology Services:

Description: Services focused on cancer prevention and early detection.

Development Stage: Planned initiative.

Target Market/Condition: Individuals at risk of cancer or seeking early detection.

Key Features and Benefits: Aims to improve public health outcomes by reducing cancer incidence and mortality.

4. Technology & Innovation

Technology Stack

MOC leverages state-of-the-art facilities and a strategic approach to technology and innovation in cancer care.

Care Delivery Model: A distributed network of community day-care centers that integrate advanced medical interventions with localized access.

Diagnostic Capabilities: In-house pathology services for high-tech genetic testing are currently in operation, with plans to develop a dedicated molecular oncology lab.

Therapeutic Modalities: Utilizes conventional chemotherapy, targeted therapy, and immunotherapy as core treatment protocols.

Scientific Methodologies: Employs multidisciplinary tumor boards for comprehensive case review and treatment planning, alongside genetic counseling services.

Proprietary Developments: While specific proprietary technologies are not detailed, MOC's innovative organizational model of accessible, affordable, and community-based cancer care is a key differentiator addressing systemic healthcare gaps in India.

Upcoming Innovations: The imminent introduction of CAR-T cell therapy stands as a significant technological advancement and innovation, set to transform the treatment landscape for certain blood cancers in India by enhancing accessibility and affordability.

5. Leadership & Management

Executive Team

M | O | C Cancer Care & Research Centre was founded by a team of highly qualified and experienced medical oncologists.

Dr. Vashishth Maniar, Director & Co-founder

Professional Background: Medical Oncologist, Hematologist, and Hematologic Oncologist with over 20 years of clinical experience. Graduated from D. Y. Patil Medical College and Rajawadi Hospital, Mumbai; completed M.D. (General Medicine) from LTMGH, Mumbai; and D.M. (Medical Oncology and Haemato-Oncology) from Gujarat Cancer and Research Institute, Ahmedabad (gold medallist).

Notable Achievements: 2015 European Society of Medical Oncology (ESMO) board-certified medical oncologist, received advanced training in lymphomas and leukemia in Germany. Active speaker at national oncology conferences.

Key Contributions: Co-founder, guiding the center's clinical excellence and strategic vision.

LinkedIn: [https://www.linkedin.com/company/mumbai-oncocare-center/](https://www.linkedin.com/company/mumbai-oncocare-center/)

Dr. Ashish Joshi, Director & Co-founder

Professional Background: Medical Oncologist and Hematologist with 14-23 years of experience. Completed M.D. medicine from Byramjee Jeejebhoy Medical College and David Sassoon Hospital, Pune, and D.M. in Medical and Paediatric Oncology and Hemato-Oncology from Gujarat Cancer Research Institute, Ahmedabad (gold medallist).

Notable Achievements: Expertise includes Molecular Oncology, Precision Medicine, and Immunotherapy. Key founder of MOC's Research Wing.

Key Contributions: Actively participates in clinical trials as a Principal Investigator and Co-Investigator, driving the research and innovation agenda.

LinkedIn: [https://www.linkedin.com/company/mumbai-oncocare-center/](https://www.linkedin.com/company/mumbai-oncocare-center/)

Dr. Pritam Kalaskar, Director & Co-founder

Professional Background: Medical and Paediatric Hemato-Oncologist with over 8 years of experience. Earned D.M. in Medical and Paediatric Oncology and Hemato-Oncology from Gujarat Cancer Research Institute, Ahmedabad (gold medal in D.M. examination).

Notable Achievements: Numerous publications in national and international journals, involved in successful bone marrow transplants.

Key Contributions: Contributing to the clinical expertise and expanding the therapeutic scope, particularly in hemato-oncology.

LinkedIn: [https://www.linkedin.com/company/mumbai-oncocare-center/](https://www.linkedin.com/company/mumbai-oncocare-center/)

Dr. Kshitij Joshi, Director & Co-founder

Professional Background: Highly accomplished Medical Oncologist with 19 years of experience. Completed D.M. in Medical and Pediatric Oncology and Hemato-Oncology from Gujarat Cancer & Research Institute, Ahmedabad, and holds the European Certification in Medical Oncology (ECMO).

Notable Achievements: Interests include solid malignancies, pediatric cancers, lymphomas, leukemia, myeloma, Immuno-oncology, and targeted therapy.

Key Contributions: Bringing extensive experience in a wide range of oncology sub-specialties, contributing to comprehensive patient care.

LinkedIn: [https://www.linkedin.com/company/mumbai-oncocare-center/](https://www.linkedin.com/company/mumbai-oncocare-center/)

Recent Leadership Changes

May 2024 Merger with Hemato Oncology Clinic (HOC): This strategic merger significantly expanded MOC's operational footprint, particularly within the state of Gujarat. The integration resulted in a combined team of 40 medical oncologists and hemato-oncologists, establishing one of India's largest pools of cancer physicians under a single organization. This change bolstered MOC's leadership in the community cancer care sector.

6. Talent and Growth Indicators

Hiring Trends and Workforce

MOC demonstrates strong growth through its expanding workforce and geographical presence.

Workforce Size: As of February 28, 2025, MOC had an employee count of 575. Its associated entity, Cellcure Cancer Centre Private Limited, reported 743 employees as of May 31, 2025.

Medical Personnel: A team of 47-55 highly qualified Medical Oncologists spearheads clinical operations.

Patient Volume: The center has treated over 4.5 lakh (450,000) patients, indicating significant operational scale and patient trust.

Geographic Footprint: Operates 24 centers across Western and Central India (Mumbai, Pune, Rest of Maharashtra, Ahmedabad, Indore, Chhattisgarh) and has an international presence in Tanzania.

Expansion Plans: Strategic plans for further expansion into Delhi NCR and other parts of India.

Current Hiring Patterns: Recruitment activities indicate a focus on clinical support, administrative roles, and talent development, signifying a robust operational and growth phase. Key roles being recruited include:

Learning & Development Specialist

Lab Technician

Resident Medical Officer (RMO)

Accountant

Wellness Lead / Psychologist / Psychology Counsellor

Front Office Receptionist

7. Social Media Presence and Engagement

Digital Footprint

M | O | C Cancer Care & Research Centre maintains an active and informative digital presence across multiple social media platforms to engage with patients, caregivers, and the general public, promoting awareness and offering insights into cancer care.